ATLANTA – A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit...
ATLANTA – Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients...
PHILADELPHIA – Among melanoma patients treated with anti-PD-1 immunotherapy, consumption of a high-fiber diet was associated with higher gut...
PHILADELPHIA – Many patients diagnosed with colorectal cancer before age 50 were initially misdiagnosed, which may lead to diagnosis...
Single test could identify one prognostic and seven predictive biomarkers in blood PHILADELPHIA – Guardant360, a liquid biopsy test...
Clinical trial data may not be generalizable to real-world population PHILADELPHIA – Patients with advanced prostate cancer who had...
The American Association for Cancer Research (AACR) will be hosting its 110th Annual Meeting, March 29-April 3, 2019, at...
SAN ANTONIO – Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better...
SAN ANTONIO – Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost weight...
SAN ANTONIO – Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could...